发明名称 MODIFIED PEPTIDE AS THERAPEUTIC AGENT
摘要 <p><P>PROBLEM TO BE SOLVED: To provide a fused protein of Fc domains with biologically active peptides and a method to prepare a medical agent using a biologically active peptide. <P>SOLUTION: The invention relates to the pharmacologically active compounds prepared by (a) selecting at least a peptide that modulates the activity of a protein of interest and (b) preparing a pharmacologic substance having an Fc domain covalently linked to at least an amino acid of the selected peptide. Linkage to the vehicle increases the half-life of the peptide, which otherwise would be quickly degraded in vivo. The preferable vehicle is the Fc domain. The peptide can be selected, for example, by phage display, E. coli display, RNA-peptide screening, chemical-peptide screening. <P>COPYRIGHT: (C)2007,JPO&INPIT</p>
申请公布号 JP2007089586(A) 申请公布日期 2007.04.12
申请号 JP20060288382 申请日期 2006.10.24
申请人 AMGEN 发明人 FEIGE ULRICH;LIU CHUAN-FA;CHEETHAM JANET;BOONE THOMAS CHARLES
分类号 C12P21/02;G01N33/50;A61K38/00;A61P3/04;A61P7/06;A61P19/02;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P35/00;A61P35/02;A61P37/02;A61P43/00;C07K;C07K14/00;C07K14/47;C07K14/505;C07K14/52;C07K14/525;C07K14/545;C07K16/00;C07K16/18;C07K19/00;C12N;C12N1/21;C12N9/64;C12N15/09;C12N15/62;C12N15/70;C12R1/19;G01N33/15;G01N33/566 主分类号 C12P21/02
代理机构 代理人
主权项
地址